C07C 255/40
The carbon skeleton being further substituted by doubly-bound oxygen atoms
Official title: the carbon skeleton being further substituted by doubly-bound oxygen atoms
C07C255/40 (The carbon skeleton being further substituted by doubly-bound oxygen atoms) appears on 80 US grants and 56 published applications in this corpus.
Search patents in C07C- Granted patents
- 80
- Published applications
- 56
- Assignees
- 66
- Inventors
- 294
- Latest grant
- 9 Apr 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1991 | 6 | 0 |
| 1992 | 5 | 0 |
| 1993 | 4 | 0 |
| 1994 | 3 | 0 |
| 1995 | 2 | 0 |
| 1996 | 2 | 0 |
| 1997 | 0 | 0 |
| 1998 | 10 | 0 |
| 1999 | 4 | 0 |
| 2000 | 2 | 0 |
| 2001 | 2 | 0 |
| 2002 | 2 | 4 |
| 2003 | 1 | 2 |
| 2004 | 1 | 4 |
| 2005 | 1 | 4 |
| 2006 | 1 | 1 |
| 2007 | 2 | 3 |
| 2008 | 3 | 2 |
| 2009 | 1 | 2 |
| 2010 | 0 | 0 |
| 2011 | 2 | 2 |
| 2012 | 0 | 2 |
| 2013 | 1 | 2 |
| 2014 | 3 | 4 |
| 2015 | 5 | 3 |
| 2016 | 2 | 4 |
| 2017 | 4 | 2 |
| 2018 | 3 | 3 |
| 2019 | 0 | 0 |
| 2020 | 3 | 3 |
| 2021 | 0 | 4 |
| 2022 | 2 | 0 |
| 2023 | 1 | 1 |
| 2024 | 2 | 3 |
| 2025 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Anticonvulsant compounds9 Apr 2024US 11,952,338 B2Owen-Barry Pharmaceuticals Inc.
- Methods and compositions for substituted arylcycloheptane analogs27 Feb 2024US 11,912,704 B2University of Florida Research Foundation, Inc.
- Materials for organic electroluminescent devices26 Sep 2023US 11,767,299 B2Merck Patent GmbH
- Anticonvulsant compounds31 May 2022US 11,345,652 B2Owen-Barry Pharmaceuticals Inc.
- Oxocarbon-, pseudooxocarbon- and radialene compounds and their use24 May 2022US 11,342,504 B2Novaled GmbH
- Anticonvulsant Compounds6 Mar 2025US 2025/0074861 A1Owen-Barry Pharmaceuticals Inc.
- Organic compound and electroluminescent device12 Sep 2024US 2024/0301284 A1Sichuan AG-Ray New Materials Co., Ltd
- New cerium (iv) complexes and their use in organic electronics25 Jul 2024US 2024/0247004 A1
- Methods and compositions for substituted arylcycloheptane analogs6 Jun 2024US 2024/0182471 A1University of Florida Research Foundation, Inc.
- Process for the production of antitumour pharmaceutical compositions using push-pull butadienes, compounds and uses thereof27 Apr 2023US 2023/0130823 A1Anhanguera Educacional ParticipaçõEs S/A
Most cited
By later US patents
- FLK-1 is a receptor for vascular endothelial growth factor90US 5,851,999 AMax-Planck-Gesellschaft Zur FöRderung Der Wissenschaften E. V. · 1998
- Quinazoline compounds and compositions thereof for the treatment of disease84US 5,792,771 ASugen, Inc. · 1998
- Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis64US 5,712,395 ASugen, Inc. · 1998
- Use of organic compounds for the inhibition of Flk-1 mediated vasculogenesis and angiogenesis60US 6,177,401 B1Max-Planck-Gesellschaft zur Forderung der Wissenschaften · 2001
- Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis53US 5,763,441 ASugen, Inc. · 1998